Ovid Therapeutics (OVID) Return on Capital Employed [ROCE] (2017 - 2026)
Ovid Therapeutics (OVID) posted Return on Capital Employed [ROCE] of -26.67% for Q2 2026, up 32.20 percentage points from -58.87% a year earlier and up 1.00 percentage points from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2025, Ovid Therapeutics' Return on Capital Employed [ROCE] came in at -37.47%, up 20.06 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +107.11 percentage points (FY2020 to FY2025).
- In prior years, Ovid Therapeutics' Return on Capital Employed [ROCE] was -57.53% in FY2024 (-14.62 pp), -42.90% in FY2023 (-9.82 pp), -33.08% in FY2022 (-136.21 pp) and 103.13% in FY2021 (+247.71 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q4 2021.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +5.02 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 216.33 percentage points; the weakest was Q4 2022, with a drop of 103.04 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -27.67% (Q1 2026), -42.82% (Q4 2025) and -64.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - | -26.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.67% |
| Mar 31, 2026 | -27.67% |
| Dec 31, 2025 | -42.82% |
| Sep 30, 2025 | -64.01% |
| Jun 30, 2025 | -58.87% |
| Mar 31, 2025 | -73.47% |
| Dec 31, 2024 | -71.22% |
| Sep 30, 2024 | -70.23% |
| Jun 30, 2024 | -61.54% |
| Mar 31, 2024 | -47.94% |
| Dec 31, 2023 | -48.17% |
| Sep 30, 2023 | -43.67% |
| Jun 30, 2023 | -41.68% |
| Mar 31, 2023 | -37.99% |
| Dec 31, 2022 | -36.27% |
| Dec 31, 2021 | 66.77% |
| Sep 30, 2021 | 63.70% |
| Jun 30, 2021 | 57.41% |
| Mar 31, 2021 | 82.24% |
| Dec 31, 2020 | -131.98% |
API Access
Ovid Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();